Across TCGA pan-cancer cohorts, RNU6-901P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-901P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU6-901P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-901P expression acts as an unfavorable survival marker, although some lineages such as OV and STAD show a favorable association.

MESO, OV, and UCEC are the cancer types where RNU6-901P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.039	0.407	<.001	36	view →
OV	OS	Tertile	III,IV	0.955	0.825	.033	18	view →
UCEC	DFS	Tertile	All	0.166	0.651	.017	12	view →
STAD	OS	Tertile	All	0.824	0.642	.031	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6-901P tumor-vs-normal RNA expression · all RNU6-901P data types